These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3694055)

  • 1. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon].
    Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL
    J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive hyperemia in patients with Raynaud's phenomenon.
    Russell A; Kappagoda T
    J Rheumatol; 1988 Nov; 15(11):1653-7. PubMed ID: 3236299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon.
    Antcliff AC; Bouhoutsos J; Martin P; Morris T
    Angiology; 1974 May; 25(5):312-6. PubMed ID: 4823806
    [No Abstract]   [Full Text] [Related]  

  • 4. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test].
    Cristol R; Debray J
    J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon.
    Whitmore SE; Wigley FM; Wise RA
    J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of misoprostol on digital circulation in patients with Raynaud's phenomenon.
    Wise RA; Wigley F
    J Rheumatol; 1994 Jan; 21(1):80-3. PubMed ID: 8151594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
    Wise RA; Malamet R; Wigley FM
    J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plethysmographic measurement of digital blood flow in Raynaud's phenomenon caused by vibrating tools].
    Casula D; Nissardi GP; Sanna-Randaccio F; Torrazza PL
    Minerva Cardioangiol; 1969 Jun; 17(6):386-98. PubMed ID: 5385423
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactive hyperemia in Raynaud's disease.
    Pratesi F; Corsi C; Deidda C; Nuti A
    Biochem Exp Biol; 1977; 13(3):337-9. PubMed ID: 16296018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finger blood flow in healthy subjects of different age and sex and in patients with primary Raynaud's disease.
    Bollinger A; Schlumpf M
    Acta Chir Scand Suppl; 1976; 465():42-7. PubMed ID: 1069432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Finger plethysmography for studying the blood rheological and hemodynamic components of an acrosyndrome].
    de Faucal P; Planchon B; Boudard D; Peltier P; Barrier J; Grolleau JY
    J Mal Vasc; 1986; 11(4):356-61. PubMed ID: 3805897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of photoplethysmography and indexes of digital pressure in Raynaud phenomenon].
    Martínez S; Lozano P; Pallarés L; Juliá J; Artigues I; Plaza A; Rimbau EM; Corominas C; Gómez FT
    Med Clin (Barc); 1999 Sep; 113(9):327-30. PubMed ID: 10562927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrasonic dopplerography and photoplethysmography in the diagnosis of Raynaud's syndrome].
    Druzhinin SO
    Revmatologiia (Mosk); 1989; (4):54-7. PubMed ID: 2700238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital pressure and flow measurement upon local cooling in Raynaud's disease. Effect of naftidrofuryl.
    Bounameaux HM; Hellemans H; Verhaege R
    Int Angiol; 1986; 5(1):39-44. PubMed ID: 3734514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
    Arneklo-Nobin B; Elmér O; Akesson A
    Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients.
    Pistorius MA; Planchon B; de Faucal P
    Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.
    Lee P; Sarkozi J; Bookman AA; Keystone EC; Armstrong SK
    J Rheumatol; 1986 Jun; 13(3):564-9. PubMed ID: 3735278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon in arterial occlusive disease.
    Tordoir JH; Winterkamp H; Dekkers W
    Neth J Surg; 1985 Aug; 37(4):97-100. PubMed ID: 4047443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.